norrin | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

386 results for “norrin”

Trials

View all 266 →

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

60 participants · First posted Apr 11, 2024

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

113 participants · First posted Sep 22, 2023

Norris ORIEN Total Cancer Care

10,000 participants · First posted Nov 21, 2016

Drugs

View all 27 →

Orris

Morin

C₁₅H₁₀O₇

NRL-011 (Norgine)

Organizations

View all 39 →

Mitsui Norin Co., Ltd.

Japan

NORTON HEALTHCARE

United States

NORGINE LIMITED

United Kingdom

News

View all 54 →

Merck's trispecific remigromig matches ranibizumab in phase 2b/3 diabetic macular edema trial

Bavarian Nordic Agrees to $3 Billion Take-Private Deal with Nordic Capital and Permira

Norgine Seeks Approval for Eflornithine in High-Risk Neuroblastoma via Project Orbis

Page 1 of 39